BNTX
BNTX
US09075V1026
BioNTech SE
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.869.900.000 2.751.100.000
4.3%
Cost of Revenue 641.800.000 541.300.000
18.6%
Gross Profit 2.228.100.000 2.209.800.000
0.8%
2.868.800.000 2.919.200.000
1.7%
Operating Income -640.700.000 -709.400.000
9.7%
Pretax Income -1.050.800.000 -677.700.000
55.1%
Net Income Common Stockholders -1.136.100.000 -665.300.000
70.8%
-- --
--
-- --
--
ende